Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2/3 1Phase 2 1

Status

Unknown 1Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 106NIH 12INDUSTRY 6OTHER_GOV 4NETWORK 2UNKNOWN 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 3Breast 1

Conditions

Stomach Neoplasms 1Rectal Neoplasms 1Neoplasm Metastasis 1Lynch syndrome I (site-specific colonic cancer) 1Breast Neoplasms 1

Interventions

Cisplatin 49Capecitabine 41apatinib 34Gemcitabine 33Oxaliplatin 32Cyclophosphamide 31Radiotherapy 29Paclitaxel 29Carboplatin 29tislelizumab 27Irinotecan 27Drug Therapy 27Fluorouracil 26Docetaxel 26Bevacizumab 23fludarabine 18Surgical Procedures, Operative 17Nivolumab 17pembrolizumab 16Exercise 16Metformin 15camrelizumab 14S 1 (combination) 14Radiation 14Pemetrexed 13Control Groups 12anlotinib 11Leucovorin 11toripalimab 10Vinorelbine 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER_GOV × Interventional × Aspirin × Clear all
NCT04214990 2024-12-27

EASTERN

National Cancer Center, Korea

Phase 3 Recruiting
1,700 enrolled
Gastrointestinal

Stomach Neoplasms

NCT03170115 2020-12-17

ICAR

Instituto Nacional de Cancer, Brazil

Phase 2 Terminated
25 enrolled
Gastrointestinal

Rectal Neoplasms

NCT03491410 2018-04-09

Breast Cancer Active Surveillance, Alternative Option, Aspirin Included

Centro Hospitalar Lisboa Ocidental

Phase 2/3 Unknown
60 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT02497820 2016-08-25

CaPP3 Israel

Tel-Aviv Sourasky Medical Center

Phase 3 Not yet recruiting
1,800 enrolled
Gastrointestinal

Lynch syndrome I (site-specific colonic cancer)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡